Epilepsy in porphyria.
Reynolds
N C
NC
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D018572:Disease-Free Survival; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D000077206:Gabapentin; D006418:Heme / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism; D008297:Male; D011164:Porphyrias / Q000150:complications*; D017094:Porphyrias, Hepatic / Q000150:complications* / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D006418:Heme; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000624:5-Aminolevulinate Synthetase